These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients. Olsson A; Höglund K; Sjögren M; Andreasen N; Minthon L; Lannfelt L; Buerger K; Möller HJ; Hampel H; Davidsson P; Blennow K Exp Neurol; 2003 Sep; 183(1):74-80. PubMed ID: 12957490 [TBL] [Abstract][Full Text] [Related]
10. Patients with the Subcortical Small Vessel Type of Dementia Have Disturbed Cardiometabolic Risk Profile. Axelsson E; Wallin A; Svensson J J Alzheimers Dis; 2020; 73(4):1373-1383. PubMed ID: 31929169 [TBL] [Abstract][Full Text] [Related]
11. Amyloid-β metabolism in Niemann-Pick C disease models and patients. Mattsson N; Olsson M; Gustavsson MK; Kosicek M; Malnar M; Månsson JE; Blomqvist M; Gobom J; Andreasson U; Brinkmalm G; Vite C; Hecimovic S; Hastings C; Blennow K; Zetterberg H; Portelius E Metab Brain Dis; 2012 Dec; 27(4):573-85. PubMed ID: 22935999 [TBL] [Abstract][Full Text] [Related]
12. Low serum HDL-cholesterol is associated with increased risk of the subcortical small vessel type of dementia. Axelsson Andrén E; Safi D; Wallin A; Svensson J Cereb Circ Cogn Behav; 2024; 6():100229. PubMed ID: 38974908 [TBL] [Abstract][Full Text] [Related]
13. Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Sennvik K; Fastbom J; Blomberg M; Wahlund LO; Winblad B; Benedikz E Neurosci Lett; 2000 Jan; 278(3):169-72. PubMed ID: 10653020 [TBL] [Abstract][Full Text] [Related]
14. Biochemical diagnosis of vascular cognitive impairment associated with subcortical small vessels disease. Liakakis G Hell J Nucl Med; 2019; 22 Suppl():187-193. PubMed ID: 30877737 [TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal Fluid Sulfatide Levels Lack Diagnostic Utility in the Subcortical Small Vessel Type of Dementia. Svensson J; Blomqvist M; Kettunen P; Eckerström C; Henricsson M; Jonsson M; Bjerke M; Månsson JE; Wallin A J Alzheimers Dis; 2021; 82(2):781-790. PubMed ID: 34092632 [TBL] [Abstract][Full Text] [Related]
16. Potential of brain age in identifying early cognitive impairment in subcortical small-vessel disease patients. Shi Y; Mao H; Gao Q; Xi G; Zeng S; Ma L; Zhang X; Li L; Wang Z; Ji W; He P; You Y; Chen K; Shao J; Mao X; Fang X; Wang F Front Aging Neurosci; 2022; 14():973054. PubMed ID: 36118707 [TBL] [Abstract][Full Text] [Related]
17. Elevation of plasma soluble amyloid precursor protein beta in Alzheimer's disease. Yun SM; Cho SJ; Jo C; Park MH; Han C; Koh YH Arch Gerontol Geriatr; 2020; 87():103995. PubMed ID: 31874328 [TBL] [Abstract][Full Text] [Related]
18. Platelet-derived secreted amyloid-precursor protein-β as a marker for diagnosing Alzheimer's disease. Marksteiner J; Humpel C Curr Neurovasc Res; 2013 Nov; 10(4):297-303. PubMed ID: 23937201 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid/serum albumin quotient (Q-Alb) is not increased in Alzheimer's disease compared to neurological disease controls: a retrospective study on 276 patients. Giacopuzzi Grigoli E; Solca F; Milone I; Aiello EN; Dubini A; Ratti A; Torresani E; Poletti B; Ticozzi N; Ciusani E; Silani V; Verde F Neurol Sci; 2023 Feb; 44(2):709-713. PubMed ID: 36441343 [TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus. Pyykkö OT; Lumela M; Rummukainen J; Nerg O; Seppälä TT; Herukka SK; Koivisto AM; Alafuzoff I; Puli L; Savolainen S; Soininen H; Jääskeläinen JE; Hiltunen M; Zetterberg H; Leinonen V PLoS One; 2014; 9(3):e91974. PubMed ID: 24638077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]